Participants to Interact Online with US FDA in Process Validation Webinar
News Jan 08, 2009
ISPE has announced plans to host a live webinar on 13 January that will allow participants to interact with representatives of the US FDA and discuss critical process validation guidelines.
The live Process Validation webinar will be held on 13 January 2009. Grace McNally, Senior Compliance Officer for the US FDA, and Paul D’Eramo, Executive Director of Johnson & Johnson, will provide insight on the FDA's draft Process Validation Guideline, highlight major concepts contained therein, discuss how the guideline may impact industry, and help participants develop a greater understanding of the document during this 90-minute live webinar.
Industry feedback will be requested on the Guidance for response directly to the FDA. D’Eramo will solicit additional comments from participants for consideration by ISPE for its official response to the FDA.
The process Validation Webinar is part of ISPE’s Online Learning series. “Learners who once sought to interact face-to-face with presenters may no longer have this option due to budget cuts for travel and other financial constraints, “ said ISPE President and CEO Robert P. Best. “We wanted to reach the widest audience possible with this important industry information and we knew that the Internet would be the best way to do that.”
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018